Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Japanese Center of Anti-Aging MedSciences (JCAM) is a Tokyo-based biotechnology and healthcare company dedicated to the advancement of longevity science and preventive medicine. The organization operates as a specialized Contract Research Organization (CRO) that facilitates clinical trials for functional foods, supplements, and medical devices, bridging the gap between academic research and commercial application. JCAM is particularly recognized for its pioneering work on Nicotinamide Mononucleotide (NMN), conducting extensive research to validate its efficacy in restoring NAD+ levels and improving metabolic health. In addition to research services, the company develops and markets high-quality, evidence-based anti-aging supplements and provides medical consulting for age-management clinics. Through collaborations with prestigious Japanese universities, JCAM remains a central figure in the scientific validation of anti-aging interventions in Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japanese Center of AntiAging MedSciences.